Precision BioSciences, Inc.DTILNASDAQ
Loading
EV/EBITDA Over TimeExpanding
Percentile Rank78
3Y CAGR-15.3%
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

3Y CAGR
-15.3%/yr
Annual compound
Percentile
P78
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
20250.58+126.3%
2024-2.20-263.0%
20231.35+41.5%
20220.96+106.5%
2021-14.79-313.5%
2020-3.58+22.4%
2019-4.61+73.2%
2018-17.21+32.9%
2017-25.67+97.6%
2016-1058.12-